Open source biotechnology: A drug for developing countries' health problems?

    Research output: Book/ReportReport

    Abstract

    In developing countries, many people suffer from diseases for which there are no drugs or for which drugs exist that they cannot afford because they are too expensive. The advent of genomics has sparked the idea that new drugs can be more easily developed and that genomics thus could lessen the health problems prevalent in developing countries. Until now, genomics has not been able to realise that promise. This paper explores whether, and if so, how open source biotechnology (hereinafter: OSB) can stimulate medical drug development specifically targeted at the health problems of developing countries.
    Original languageEnglish
    Place of Publicationonbekend
    PublisherTilburg Institute for Law Technology and Society
    Publication statusPublished - 2008

    Fingerprint Dive into the research topics of 'Open source biotechnology: A drug for developing countries' health problems?'. Together they form a unique fingerprint.

    Cite this